Integra LifeSciences (IART)
(Delayed Data from NSDQ)
$30.61 USD
+1.30 (4.44%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $30.62 +0.01 (0.03%) 5:26 PM ET
3-Hold of 5 3
A Value F Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/24/24 |
---|---|
Current Quarter | 0.64 |
EPS Last Quarter | 0.55 |
Last EPS Surprise | 0.00% |
ABR | 2.89 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.04 |
Next Year | 3.29 |
EPS (TTM) | 2.91 |
P/E (F1) | 9.64 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 412.30M | 431.40M | 1.68B | 1.75B |
# of Estimates | 7 | 8 | 7 | 8 |
High Estimate | 413.00M | 438.48M | 1.68B | 1.79B |
Low Estimate | 411.28M | 412.23M | 1.67B | 1.67B |
Year ago Sales | 381.27M | 382.42M | 1.54B | 1.68B |
Year over Year Growth Est. | 8.14% | 12.81% | 8.69% | 4.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.64 | 0.85 | 3.04 | 3.29 |
# of Estimates | 8 | 7 | 9 | 9 |
Most Recent Consensus | 0.62 | 0.84 | 3.04 | 3.28 |
High Estimate | 0.74 | 0.88 | 3.17 | 3.51 |
Low Estimate | 0.60 | 0.84 | 3.00 | 3.04 |
Year ago EPS | 0.71 | 0.76 | 3.10 | 3.04 |
Year over Year Growth Est. | -9.86% | 11.84% | -1.94% | 8.30% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.64 | 0.85 | 3.04 | 3.29 |
7 Days Ago | 0.64 | 0.85 | 3.04 | 3.29 |
30 Days Ago | 0.66 | 0.86 | 3.04 | 3.29 |
60 Days Ago | 0.66 | 0.86 | 3.04 | 3.29 |
90 Days Ago | 0.76 | 0.88 | 3.19 | 3.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.64 | 0.85 | 3.04 | 3.29 |
Zacks Consensus Estimate | 0.64 | 0.85 | 3.04 | 3.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.55 | 0.89 | 0.76 | 0.71 | NA |
Estimate | 0.55 | 0.90 | 0.78 | 0.57 | NA |
Difference | 0.00 | -0.01 | -0.02 | 0.14 | 0.03 |
Surprise | 0.00% | -1.11% | -2.56% | 24.56% | 5.22% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more